Translate Bio's Series C Round

Translate Bio raised a round of funding on January 05, 2017.

Translate Bio (NASDAQ: TBIO), formerly RaNA Therapeutics, is a biotechnology company committed to the development of next generation RNA-targeted medicines. The company's mission is to improve the liv…

Articles about Translate Bio's Series C Round: